Literature DB >> 16563549

The association of total and differential white blood cell count with metabolic syndrome in type 2 diabetic patients.

Wan Sub Shim1, Hae Jin Kim, Eun Seok Kang, Chul Woo Ahn, Sung Kil Lim, Hyun Chul Lee, Bong Soo Cha.   

Abstract

AIMS: We investigated the relation between total and differential white blood cell (WBC) count and metabolic syndrome (MS) in type 2 diabetic patients.
METHODS: Eight-hundred and twenty-two patients (males 430, females 392, BMI 25.4+/-3.2 kg/m2, duration of diabetes 5.7+/-6.8 years) were enrolled in this study. We measured total WBC count and differential count, anthropometry, blood pressure, fasting glucose, insulin and lipid profiles.
RESULTS: The number of components of MS and prevalence of MS were increased from 1st quartile to 4th quartile of WBC count. Total WBC, neutrophil, lymphocyte, monocyte and eosinophil counts were increased with the increase of number of components of MS except basophil count. Total WBC, neutrophil, lymphocyte, monocyte and eosinophil counts were higher in the patients with MS features than those without MS features. WBC count was positively correlated with waist circumference (gamma=0.134), systolic blood pressure (gamma=0.082), diastolic blood pressure (gamma=0.083), triglyceride (gamma=0.241), insulin (gamma=0.222), and HOMA-IR (gamma=0.225), and negatively with HDL cholesterol (gamma=-0.146) (p<0.05, respectively).
CONCLUSIONS: Chronic inflammation, as indicated by a higher WBC count, may be related with the increased number of components of MS in type 2 diabetic patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16563549     DOI: 10.1016/j.diabres.2006.02.001

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  38 in total

Review 1.  Adrenal steroids and the metabolic syndrome.

Authors:  Stephen P Thomson; Craig S Stump; L Romayne Kurukulasuriya; James R Sowers
Journal:  Curr Hypertens Rep       Date:  2007-12       Impact factor: 5.369

2.  The relevance of inflammatory markers in metabolic syndrome.

Authors:  Genel Sur; Emanuela Floca; Liana Kudor-Szabadi; Maria Lucia Sur; Daniel Sur; Gabriel Samasca
Journal:  Maedica (Buchar)       Date:  2014-03

3.  Lymphocytes and immunoglobulin patterns across the threshold of severe obesity.

Authors:  Paolo Marzullo; Alessandro Minocci; Paola Giarda; Cecilia Marconi; Antonella Tagliaferri; Gillian E Walker; Massimo Scacchi; Gianluca Aimaretti; Antonio Liuzzi
Journal:  Endocrine       Date:  2013-06-26       Impact factor: 3.633

4.  High density lipoproteins and type 2 inflammatory biomarkers are negatively correlated in atopic asthmatics.

Authors:  Amisha V Barochia; Elizabeth M Gordon; Maryann Kaler; Rosemarie A Cuento; Patricia Theard; Debbie M Figueroa; Xianglan Yao; Nargues A Weir; Maureen L Sampson; Mario Stylianou; David F Choy; Cecile T J Holweg; Alan T Remaley; Stewart J Levine
Journal:  J Lipid Res       Date:  2017-06-27       Impact factor: 5.922

5.  Assessment of human lymphocyte proliferation associated with metabolic syndrome.

Authors:  O A Pinzón; J C Sánchez; J C Sepúlveda-Arias; D F López-Zapata
Journal:  J Endocrinol Invest       Date:  2015-05-16       Impact factor: 4.256

6.  Mild renal dysfunction and metabolites tied to low HDL cholesterol are associated with monocytosis and atherosclerosis.

Authors:  Anjali Ganda; Martin Magnusson; Laurent Yvan-Charvet; Bo Hedblad; Gunnar Engström; Ding Ai; Thomas J Wang; Robert E Gerszten; Olle Melander; Alan R Tall
Journal:  Circulation       Date:  2013-02-01       Impact factor: 29.690

7.  Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia.

Authors:  Michiel E Stegenga; Saskia N van der Crabben; Regje M E Blümer; Marcel Levi; Joost C M Meijers; Mireille J Serlie; Michael W T Tanck; Hans P Sauerwein; Tom van der Poll
Journal:  Blood       Date:  2008-03-03       Impact factor: 22.113

Review 8.  Innate Immune Cells in the Adipose Tissue in Health and Metabolic Disease.

Authors:  Zoi Michailidou; Mario Gomez-Salazar; Vasileia Ismini Alexaki
Journal:  J Innate Immun       Date:  2021-04-13       Impact factor: 7.349

9.  Oxidant/antioxidant status in Type-2 diabetes mellitus patients with metabolic syndrome.

Authors:  Ali Najafi; Morteza Pourfarzam; Fouzieh Zadhoush
Journal:  J Res Med Sci       Date:  2021-01-28       Impact factor: 1.852

10.  White blood cell counts as risk markers of developing metabolic syndrome and its components in the PREDIMED study.

Authors:  Nancy Babio; Núria Ibarrola-Jurado; Mònica Bulló; Miguel Ángel Martínez-González; Julia Wärnberg; Itziar Salaverría; Manuel Ortega-Calvo; Ramón Estruch; Lluís Serra-Majem; Maria Isabel Covas; José Vicente Sorli; Jordi Salas-Salvadó
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.